Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cardinal Health (CAH)

Cardinal Health (CAH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 50,355,272
  • Shares Outstanding, K 235,316
  • Annual Sales, $ 222,578 M
  • Annual Income, $ 1,561 M
  • EBIT $ 3,052 M
  • EBITDA $ 3,842 M
  • 60-Month Beta 0.64
  • Price/Sales 0.23
  • Price/Cash Flow 18.26
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 34.96% (+0.51%)
  • Historical Volatility 18.50%
  • IV Percentile 94%
  • IV Rank 85.87%
  • IV High 37.59% on 10/16/25
  • IV Low 19.00% on 06/26/25
  • Expected Move (DTE 4) 4.96 (2.32%)
  • Put/Call Vol Ratio 0.82
  • Today's Volume 1,936
  • Volume Avg (30-Day) 1,387
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 36,923
  • Open Int (30-Day) 37,116
  • Expected Range 209.03 to 218.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $2.81
  • Number of Estimates 7
  • High Estimate $3.01
  • Low Estimate $2.75
  • Prior Year $2.35
  • Growth Rate Est. (year over year) +19.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
203.86 +4.55%
on 03/24/26
217.77 -2.13%
on 04/09/26
+5.30 (+2.55%)
since 03/20/26
3-Month
203.86 +4.55%
on 03/24/26
233.60 -8.76%
on 03/02/26
+2.76 (+1.31%)
since 01/20/26
52-Week
129.52 +64.55%
on 04/21/25
233.60 -8.76%
on 03/02/26
+78.42 (+58.21%)
since 04/17/25

Most Recent Stories

More News
Cardinal Health report highlights growing momentum to expand advanced therapies into community care settings

Research confirms advanced therapies are moving beyond inpatient hospitals, with providers increasingly supporting partnerships that bring life-changing treatments closer to patients' homes.

CAH : 213.13 (-0.40%)
1 Large-Cap Stock to Consider Right Now and 2 That Underwhelm

1 Large-Cap Stock to Consider Right Now and 2 That Underwhelm

FISV : 63.50 (-0.73%)
ADBE : 243.90 (-0.22%)
CAH : 213.13 (-0.40%)
Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies

DUBLIN, Ohio , April 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced a significant expansion of its Actinium-225 (Ac-225) production capabilities at the company's Center for Theranostics...

CAH : 213.13 (-0.40%)
2 Cash-Producing Stocks with Competitive Advantages and 1 We Brush Off

2 Cash-Producing Stocks with Competitive Advantages and 1 We Brush Off

OMC : 78.67 (-0.11%)
UTI : 38.05 (-0.52%)
CAH : 213.13 (-0.40%)
3 Dividend Aristocrat Stocks Up 200% That Nobody Is Talking About

Three top-performing Dividend Aristocrats delivered big 5-year gains, steady dividend growth, and still look positioned for more upside ahead.

CAT : 789.53 (-0.64%)
XOM : 148.20 (+1.20%)
CAH : 213.13 (-0.40%)
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30

DUBLIN, Ohio , March 24, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2026 on April 30 as previously indicated, prior to the...

CAH : 213.13 (-0.40%)
Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair

DUBLIN, Ohio , March 23, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that its Board of Directors has appointed Patricia A. Hemingway Hall to succeed Gregory B. Kenny as Chair...

CAH : 213.13 (-0.40%)
Is Cardinal Health Stock Outperforming the Dow?

As Cardinal Health has outpaced the Dow over the past year, analysts remain bullish about the stock’s prospects.

MCK : 860.01 (-0.74%)
$DOWI : 49,447.43 (+1.79%)
CAH : 213.13 (-0.40%)
2 S&P 500 Stocks with Solid Fundamentals and 1 We Turn Down

2 S&P 500 Stocks with Solid Fundamentals and 1 We Turn Down

HCA : 486.99 (-0.21%)
TXN : 231.50 (+0.73%)
CAH : 213.13 (-0.40%)
When Fear Hits the Stock Market, Where Can Investors Find Safety?

Our senior market strategist takes a look at traditionally defensive sectors to find opportunities in the current market uncertainty.

$VIX : 19.20 (+9.84%)
JNJ : 234.30 (+0.05%)
CAH : 213.13 (-0.40%)
MRNA : 53.28 (-0.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and...

See More

Key Turning Points

3rd Resistance Point 220.20
2nd Resistance Point 217.39
1st Resistance Point 215.69
Last Price 213.13
1st Support Level 211.19
2nd Support Level 208.39
3rd Support Level 206.69

See More

52-Week High 233.60
Last Price 213.13
Fibonacci 61.8% 193.84
Fibonacci 50% 181.56
Fibonacci 38.2% 169.28
52-Week Low 129.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.